Soluble epoxide hydrolase and ischemic cardiomyopathy
Ting-Ting Zhao1, Binaya Wasti, Dan-Yan Xu
1Department of Cardiovascular Internal Medicine, Second Xiangya Hospital, Central South University Changsha, 410011, PR China.
International Journal of Cardiology
|June 28, 2011
Summary
Lowered epoxyeicosatrienoic acids (EETs) are linked to cardiovascular disease. Soluble epoxide hydrolase inhibitors (sEHIs) show promise in treating ischemic cardiomyopathy by increasing EETs levels.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Pharmacology
Background:
- Cardiovascular disease development is associated with reduced epoxyeicosatrienoic acids (EETs).
- Ischemic cardiomyopathy, characterized by atherosclerotic lesions, leads to myocardial dysfunction and heart failure.
- The EPHX2 gene encodes soluble epoxide hydrolase (sEH), which metabolizes EETs and has known polymorphisms linked to cardiovascular disease.
Purpose of the Study:
- To investigate the role of sEH in ischemic cardiomyopathy.
- To explore the therapeutic potential of sEH inhibitors (sEHIs) in cardiovascular diseases.
Main Methods:
- Review of existing research on sEH, EETs, and their role in cardiovascular pathology.
- Analysis of the mechanisms by which sEHIs modulate EETs levels and cardiovascular function.
Main Results:
- sEH activity and polymorphisms are implicated in cardiovascular diseases.
- sEHIs effectively increase EETs concentrations by inhibiting EETs hydration.
- sEHIs demonstrate potential in preventing atherosclerosis, improving coronary artery function, and mitigating ischemia-reperfusion injury.
Conclusions:
- Soluble epoxide hydrolase (sEH) is an etiological factor in cardiovascular diseases, particularly in the progression of myocardial ischemia.
- Soluble epoxide hydrolase inhibitors (sEHIs) represent a novel therapeutic strategy for the prevention and treatment of ischemic cardiomyopathy.
Related Concept Videos
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...